BioCentury
ARTICLE | Clinical News

Rexahn preclinical data

May 12, 2014 7:00 AM UTC

In mouse xenograft models of cancer, RX-21101 completely inhibited tumor growth, enhanced tumor regression and improved survival without significant changes in body weight compared to IV docetaxel. Da...